“Estimated Conjunctivitis-Related Healthcare Cost Savings With Increased Tralokinumab Use Versus Other Biologics Among Patients With Moderate-Severe Atopic Dermatitis in the United States”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s630. Accessed May 1, 2026. https://skin.dermsquared.com/skin/article/view/3919.